Delivery Order SPE2DB24D9144-SPE2DB25FCMNU

Award Date 4/2/25
Potential Completion Date 4/23/25
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to supply a variety of pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. The delivery order, valued at $4,169.59, is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities worldwide. The contract, valued up to $1,543.92, covers the delivery of various medications including branded and generic prescription drugs, over-the-counter products, biologics, and...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the supply of various pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health facilities worldwide. The delivery order, valued at $7,104.00, is part of...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a wide range of pharmaceutical products and medical supplies. This order, valued at $2,319.51, is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group that has a ceiling value of up to $499,999,999. The IDC, under the DLA's SPE2DB program, allows the agency to issue delivery orders for a comprehensive...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of a variety of pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. The contract, valued at $7,104.00, has an ultimate completion date of August 28, 2024. This delivery order falls under a larger indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities worldwide. The contract, valued at $1,221.12, is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which has a ceiling value of up to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract, valued at $1,481.80, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The delivery order, which is part of the DLA's Medical Supply Chain division SPE2DB program, is for the supply of pharmaceutical products, including prescription drugs, over-the-counter medications, and medical consumables, to support the recurring medical supply needs of...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $2,443.50 to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valid through April 2025, is for the provision of pharmaceutical products and medical supplies to the DLA's Medical Supply Chain. This contract is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) awarded to DMS Pharmaceutical Group, enabling the DLA to issue delivery orders for a comprehensive...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. The contract, valued at $2,005.44, has an ultimate completion date of April 22, 2022. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC)...
The Defense Logistics Agency (DLA) awarded a $18,318.75 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a variety of pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) with DMS Pharmaceutical Group that allows the DLA to issue firm fixed-price delivery...
  • SPE2DB24D9144
    Indefinite Delivery Contract
  • SPE2DB24D9144-SPE2DB25FCMNU
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. The contract, valued at $2,783.55, has an ultimate completion date of April 23, 2025. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, which enables the DLA to issue orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation.

Generated 7/2/25, 11:03 PM